Cholesterol Uptake by Cryptosporidium

隐孢子虫摄取胆固醇

• 批准号: 7749888
• 负责人: Isabelle Coppens
• 金额: $ 20.5万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-06-25 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7749888
• 关键词: 3-hydroxy-3-methylglutaryl-coenzyme A; AIDS/HIV problem; ATP-Binding Cassette Transporters; Abbreviations; Acquired Immunodeficiency Syndrome; Amino Acids; Binding; Biological Models; Brush Border; Cell membrane; Cells; Cholesterol; Cholesterol Esters; Cholesterol Homeostasis; Collection; Complement component C1s; Complex; Cryptosporidiosis; Cryptosporidium; Cytoplasm; Data; Development; Disease; Drug Delivery Systems; Drug resistance; Endocytosis; Endoplasmic Reticulum; Ensure; Enterocytes; Environment; Epithelial; Epithelial Cells; Excision; Exhibits; Gastrointestinal tract structure; Genes; Goals; Growth; Homologous Gene; Immunocompromised Host; Individual; Infection; Intake; Intercept; Intestines; Invaded; Life; Light; Lipids; Lipoproteins; Location; Low Density Lipoprotein Receptor; Low-Density Lipoproteins; Mammalian Cell; Mammals; Membrane; Modification; Molecular; Movement; Nature; Nuclear Pore Complex; Nucleotides; Nutrient; Oocysts; Opportunistic Infections; Organelles; Organism; Parasites; Pathogenicity; Pathway interactions; Patients; Plasma; Plasmodium; Proteins; Relative (related person); Reliance; Reproduction; Resources; Role; Serum; Site; Small Intestines; Source; Sporozoites; Staging; Starvation; Steroids; Sterol O-Acyltransferase; Sterols; Surface; Thin Layer Chromatography; Toxoplasma gondii; Vacuole; Water; base; chemotherapy; cholesterol absorption; cholesterol biosynthesis; cholesterol trafficking; citrate carrier; dehydroergosterol; drug standard; experience; extracellular; inter-alpha-inhibitor; intraepithelial; meetings; microbial; novel; novel strategies; oxysterol binding protein; parasite genome; pathogen; permease; public health relevance; receptor mediated endocytosis; stem; uptake

DESCRIPTION (provided by applicant): Cryptosporidiosis is universally recognized as one of the most serious opportunistic infections that complicates AIDS. Cryptosporidium infection begins with microbial invasion of small intestinal epithelial cells (enterocytes), in which the parasite creates a peculiar niche that sequesters itself from the intestinal lumen and the host cell's cytoplasm. After amplification, endogenous parasites escape from the parasitophorous vacuole and spread throughout the epithelial surfaces of the gastrointestinal tract. No consistently reliable chemotherapy is available for the treatment of cryptosporidiosis. The need for identifying novel drug targets is imperative. Interactions of Cryptosporidium with enterocytes remain poorly characterized. Undeniably, this parasite must depend on various host cell resources since it has lost the ability to synthesize most basic metabolites. We demonstrated that Cryptosporidium developing in enterocytes contains significant amounts of cholesterol though it lacks the genes for cholesterol biosynthesis and modification. The parasite critically relies on host cholesterol for normal development since removal of cholesterol either from the medium or host cell intracellular pools, arrests its reproduction. Our overall goal is to decipher the mechanism/s for host cholesterol acquisition by Cryptosporidium. We hypothesize that the choice of enterocytes as the major sites for parasite replication may stem from the unique cholesterol transport and synthesis activities of these cells. Cryptosporidium must be equipped to intercept host cholesterol, either provided exogenously by the plasma and/or the gut, or synthesized in enterocytes. Specific Aim 1 will define the preferential source of host derived-cholesterol for Cryptosporidium and analyze the mechanisms of cholesterol delivery from the host enterocyte to the PV. We will investigate the contribution of i) the plasma low-density lipoprotein receptor-mediated endocytosis, ii) the micellar cholesterol absorption by the permease Niemann-Pick C1-like 1, and iii) the cholesterol biosynthetic pathway, to parasite growth. We documented the presence of sterols on the parasite's plasma membrane and organelles indicating that Cryptosporidium is able to internalize host cholesterol to its cell interior. Specific Aim 2 will decipher the molecular machinery developed by Cryptosporidium to transport cholesterol from the parasite surface to organelles. We will focus on the characterization of two classes of surface-exposed sterol transporters, the ATP-binding cassette G1 transporter and Niemann-Pick C1 protein present in the parasite, for cholesterol trafficking. Our long-term objective is to provide novel approaches to treat cryptosporidiosis, based on blocking the parasite's intracellular development through cholesterol starvation. Exploration of the peculiarities of cholesterol uptake by Cryptosporidium will expose new vulnerabilities. Cryptosporidium may also provide a useful model system for throwing light on cholesterol homeostatic and dysregulatory pathways in mammalian enterocytes. PUBLIC HEALTH RELEVANCE: Cryptosporidium is one of the most troublesome agents of water-borne disease that cause life-threatening disease in HIV/AIDS patients. This parasite develops inside intestinal epithelial cells where it remains protected from the hostile gut environment and is supplied with host nutrients. We will study the mechanisms by which the parasite scavenges host cholesterol, in order to specifically interfere with the pathogen's supply of this essential lipid, thereby causing its growth arrest through starvation.

描述（由申请人提供）：隐孢子虫病是公认的最严重的机会性感染，使艾滋病并发症之一。隐孢子虫感染开始于微生物侵入小肠上皮细胞（肠上皮细胞），其中寄生虫创造了一个特殊的生态位，将自身与肠腔和宿主细胞的细胞质隔离。扩增后，内源性寄生虫从寄生虫液泡中逸出，并扩散到整个胃肠道的上皮表面。隐孢子虫病的治疗尚无可靠的化疗方法。确定新的药物靶点的必要性是迫切的。隐孢子虫与肠上皮细胞的相互作用仍不清楚。不可否认，这种寄生虫必须依赖各种宿主细胞资源，因为它已经失去了合成大多数基本代谢物的能力。我们证明，在肠细胞中发育的隐孢子虫含有大量胆固醇，尽管它缺乏胆固醇生物合成和修饰的基因。寄生虫的正常发育严重依赖宿主胆固醇，因为从培养基或宿主细胞内池中去除胆固醇会阻止其繁殖。我们的总体目标是破译隐孢子虫获取宿主胆固醇的机制。我们推测，选择肠上皮细胞作为寄生虫复制的主要场所可能源于这些细胞独特的胆固醇转运和合成活动。隐孢子虫必须具备拦截宿主胆固醇的能力，这些胆固醇要么是由血浆和/或肠道外源性提供的，要么是在肠上皮细胞中合成的。具体目标1将确定隐孢子虫的宿主衍生胆固醇的优先来源，并分析胆固醇从宿主肠上皮细胞输送到PV的机制。我们将研究i）血浆低密度脂蛋白受体介导的内吞作用，ii）通透酶Niemann-Pick C1-like 1的胶束胆固醇吸收，iii）胆固醇生物合成途径对寄生虫生长的贡献。我们记录了寄生虫的质膜和细胞器上的甾醇的存在，表明隐孢子虫能够将宿主胆固醇内化到其细胞内部。特定目标2将破译隐孢子虫将胆固醇从寄生虫表面转运到细胞器的分子机制。我们将专注于表征两类表面暴露的甾醇转运蛋白，ATP结合盒G1转运蛋白和尼曼-匹克C1蛋白存在于寄生虫，胆固醇运输。我们的长期目标是提供新的方法来治疗隐孢子虫病，基于通过胆固醇饥饿阻断寄生虫的细胞内发育。探索隐孢子虫摄取胆固醇的特殊性将暴露新的漏洞。隐孢子虫也可能提供一个有用的模型系统，在哺乳动物肠细胞胆固醇稳态和失调途径投掷光。公共卫生关系：隐孢子虫是最棘手的水传播疾病的病原体之一，可导致危及HIV/AIDS患者生命的疾病。这种寄生虫在肠上皮细胞内发育，在那里它仍然受到保护，免受恶劣的肠道环境的影响，并获得宿主营养。我们将研究寄生虫清除宿主胆固醇的机制，以特异性地干扰病原体对这种必需脂质的供应，从而通过饥饿引起其生长停滞。